QUEENS HOSPITAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $2.7M
- Transactions
- 189
- Companies
- 18
- Average per transaction
- $14,300
Who reported the payments
| Gilead | $1,833,983 |
| Regeneron | $695,999 |
| IBSA Institut Biochimique SA | $103,087 |
| Blue Earth Diagnostics | $23,095 |
| Aesculap, Inc. | $14,196 |
| Novartis | $13,514 |
| Beckman Coulter, Inc. | $11,710 |
| KARL Storz Endoscopy-america | $3,763 |
| C. R. Bard, Inc. & Subsidiaries | $650 |
| Leica Microsystems Inc. | $623 |
| Merit Medical Systems Inc | $449 |
| Janssen Research & Development, LLC | $375 |
| Fisher Scientific Company L.L.C. | $345 |
| Convatec Inc. | $311 |
| Amgen | $310 |
| Medline Industries LP | $183 |
| Olympus America Inc. | $84 |
| Aspen Surgical Products, Inc. | $5 |